Moderna
FDA approves world's first mRNA-based flu vaccine, signaling start of a new illness-prevention era
The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.
Breakthrough CMV vaccine offers hope to pregnant women
Health Ministry issues recommendation for Moderna COVID vaccine
Moderna says updated COVID vaccine is effective against newer variant
Can mRNA technology used in COVID-19 vaccines be used to cure cancer?
Messenger RNA (mRNA) relies on synthetic genes that can be generated and manufactured in weeks, and produced more rapidly than conventional vaccines.
Why could you still get COVID-19 after receiving a vaccine?
The Pfizer and Moderna COVID-19 vaccines are around 95% effective but some people still get sick with coronavirus after getting their shots. Here's why.
Vaccination program for Palestinian workers to resume after delay
During an initial pilot of the program held Thursday, some 700 Palestinians received their first dose of the vaccine.
Vaccinated nursing mothers appear to pass on antibodies to their children
According to the report, no adverse effects were discovered among the babies, leading researchers to believe that the babies may be protected from COVID-19 through breast milk antibodies.
After record COVID-19 deaths, Bolsonaro tells Brazilians to stop 'whining'
While the US outbreak is ebbing, Brazil is facing its worst phase of the epidemic yet, pushing its hospital system to the brink of collapse.
Grapevine March 3, 2021: It did not rain on his parade
Movers and shakers in Israeli society.
US authorizes Johnson & Johnson's COVID-19 vaccine
The US Food and Drug Administration announced the emergency use authorization of the J&J vaccine for adults aged 18 & older following Friday's unanimous endorsement by the agency's panel of experts.
Coronavirus in Israel: Palestinian workers to receive Moderna vaccines
Some 5,000 Moderna vaccines were committed to the PA to inoculate its healthcare workers, of which only 2,000 have been delivered.
Moderna expects $18.4 billion in COVID-19 vaccine sales in 2021
It now aims to produce at least 700 million doses this year and expects to raise production to as much as 1 billion doses by improving its manufacturing process..
Moderna is developing booster shot for new coronavirus variants
Moderna is experimenting with several potential ways to combat new variants of the virus.
